Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yixintang is one of China’s largest pharmaceutical retailers and distributors, operating over 1,500 pharmacies across the country. It manufactures traditional Chinese medicines (TCM), modern pharmaceuticals, health supplements, and distributes both its own-branded products as well as third-party drugs. The company has seen strong revenue growth driven by expansion in both physical stores and e-commerce channels[5][1][2]. There are no clinical trial results reported as it does not operate as an innovative drug developer but rather focuses on established medicines[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yixintang Pharmaceutical Group.